Related Experiment Videos
Four EBNA2 domains are important for EBNALP coactivation
Chih-Wen Peng1, Bo Zhao, Elliott Kieff
1Department of Medicine and Microbiology and Molecular Genetics, Channing Laboratory, Brigham and Women's Hospital, and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA.
Journal of Virology
|September 29, 2004
Summary
Epstein-Barr virus nuclear antigen 2 (EBNA2) and EBNA2-associated protein (EBNALP) are key for B-lymphocyte growth. This study identifies a new EBNA2 domain (E2AD2) crucial for EBNALP coactivation in Epstein-Barr virus infection.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Epstein-Barr virus (EBV) infection transforms primary B-lymphocytes.
- EBNA2-mediated transcriptional activation and EBNALP coactivation are essential for this transformation.
- EBNALP coactivation is known to involve the EBNA2 acidic activation domain (E2AD).
Purpose of the Study:
- To investigate the interaction between EBNALP and EBNA2.
- To identify novel functional domains within EBNA2 involved in coactivation.
- To elucidate the role of these domains in Epstein-Barr virus-driven B-lymphocyte proliferation.
Main Methods:
- Protein-protein interaction assays to map binding sites between EBNALP and EBNA2.
- Functional assays measuring transcriptional activation and coactivation.
- Analysis of EBNA2 domains, including E2AD and a newly identified E2AD2 region.
Main Results:
- EBNALP binds to E2AD, a known transcriptional activation domain of EBNA2.
- A second transcriptional activation domain, E2AD2 (amino acids 1-58 of EBNA2), was identified.
- EBNALP specifically coactivates E2AD2, and both E2AD and E2AD2, along with other EBNA2 domains, play significant roles in EBNA2-mediated activation and EBNALP coactivation.
Conclusions:
- EBNALP coactivation is mediated by multiple domains within EBNA2, including the newly identified E2AD2.
- These findings enhance understanding of the molecular mechanisms underlying EBV-induced B-cell transformation.
- Targeting these interactions could offer new strategies for controlling EBV-associated diseases.